• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2015 - 2021年印度不同分类下高血压前期(血压升高或血压正常高值)的患病率及决定因素:来自大型全国性调查的证据

Prevalence and determinants of prehypertension (elevated blood pressure or high normal BP) according to different classifications in India during 2015-2021: Evidence from the large national surveys.

作者信息

Singh Geetu, Agrawal Renu, Kumar Sanjeev, Kumar Shubham, Negi Rudresh, Goel Sonu, Agarwal Tanya

机构信息

Department of Community Medicine, Sarojini Naidu Medical College, Agra, Uttar Pradesh, India.

Department of Community and Family Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.

出版信息

PLoS One. 2025 Jun 11;20(6):e0325437. doi: 10.1371/journal.pone.0325437. eCollection 2025.

DOI:10.1371/journal.pone.0325437
PMID:40498809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12157057/
Abstract

BACKGROUND

Since the advent of American Joint National Commission (JNC-7) guidelines, epidemiological studies have reported that prehypertension is a common presentation in the general population, with a prevalence of 25% to 55% globally. The present study aimed to estimate the prevalence of prehypertension (elevated blood pressure or high normal BP) and its determinants based on different standard classifications using the large population-based data from the fourth and fifth rounds of National Family Health Surveys (NHFS), India. We also intended to identify the trends of prehypertension between NFHS-4 and NFHS-5 at national, state and district levels.

METHODS

We analyzed the data from the National Family Health Surveys (NFHS) 4 and 5 conducted in 2015-16 and 2019-20, respectively. Prevalence of pre-hypertension and its equivalent terms, elevated blood pressure and high normal BP was reported as per the Joint National Committee (JNC 7), 2017 American College of Cardiology/American Heart Association (ACC/AHA), and Indian Guidelines for Hypertension (IGH -IV) respectively. GeoDa (spatial and cluster maps) was used to compute Local Indicators of Spatial Association (LISA). We also calculated Moran's Index to explain the data's overall clustering and project the strength and patterns of spatial autocorrelation to represent district-level results.

RESULTS

Prevalence of prehypertension (elevated blood pressure or high normal BP) showed an increasing trend across all three classifications from NFHS-4 to NFHS-5 in India (35.8% vs. 48.8% as per JNC 7, 6.1% vs 8.8% as per ACC/AHA and 12.5% vs 20.8% according to IGH-IV). Age > 29 years was significant risk factors for pre-hypertension in both the surveys as per JNC 7 and IGH -IV guidelines. Women had higher odds of having prehypertension according to all three guidelines in both surveys. Education had a protective effect across classifications as evident from NFHS-5 data, which was variable in the previous NFHS-4 survey. The prevalence of prehypertension (JNC 7/8) has increased above 50% in NFHS-5 survey in most states of India, namely, Delhi, most districts of Punjab, Himachal Pradesh, Haryana, Rajasthan, Uttarakhand, Uttar Pradesh, Chhattisgarh, Madhya Pradesh, Jharkhand, Odisha, Manipur, Mizoram, Arunachal Pradesh, Tamil Nadu, Lakshadweep and Andaman and Nicobar Islands. However, Goa, Sikkim, Assam, Nagaland and West Bengal demonstrated a declining trend in prevalence of prehypertension. In NFHS-5, 117 districts were observed as hotspots ("high-high" clustering) clustered zones, mostly in Arunachal Pradesh, Rajasthan, Madhya Pradesh, Uttar Pradesh, and Punjab.

CONCLUSION

We found a high prevalence of prehypertension in large population based survey in Indian population. The findings also highlighted marked differences in estimates of prehypertension (elevated blood pressure or high normal BP) based on different classifications. These results will help guide researchers, public health policymakers and clinicians to uniformly define prehypertension for its effective management. These trends should be considered as an interim warning signal to formulate guidelines with strong implementation of interventions to prevent and control prehypertension and hypertension.

摘要

背景

自美国国家联合委员会(JNC - 7)指南问世以来,流行病学研究报告称,高血压前期在普通人群中很常见,全球患病率为25%至55%。本研究旨在利用印度第四轮和第五轮全国家庭健康调查(NHFS)的大量基于人群的数据,根据不同的标准分类估算高血压前期(血压升高或血压正常高值)的患病率及其决定因素。我们还打算确定在国家、邦和地区层面上,NFHS - 4和NFHS - 5之间高血压前期的趋势。

方法

我们分别分析了2015 - 16年和2019 - 20年进行的全国家庭健康调查(NFHS)4和5的数据。高血压前期及其等效术语,即血压升高和血压正常高值的患病率分别根据美国国家联合委员会(JNC 7)、2017年美国心脏病学会/美国心脏协会(ACC/AHA)以及印度高血压指南(IGH - IV)进行报告。使用GeoDa(空间和聚类地图)来计算空间关联局部指标(LISA)。我们还计算了莫兰指数,以解释数据的总体聚类情况,并预测空间自相关的强度和模式,以呈现地区层面的结果。

结果

在印度,从NFHS - 4到NFHS - 5,所有三种分类中高血压前期(血压升高或血压正常高值)的患病率均呈上升趋势(根据JNC 7为35.8%对48.8%,根据ACC/AHA为6.1%对8.8%,根据IGH - IV为12.5%对20.8%)。根据JNC 7和IGH - IV指南,在两项调查中,年龄大于29岁都是高血压前期的重要危险因素。在两项调查中,根据所有三项指南,女性患高血压前期的几率都更高。从NFHS - 5数据可以明显看出,教育在所有分类中都具有保护作用,而在之前NFHS - 4调查中这种作用并不一致。在印度大多数邦,即德里、旁遮普邦的大多数地区、喜马偕尔邦、哈里亚纳邦、拉贾斯坦邦(Rajasthan)、北阿坎德邦、北方邦、恰蒂斯加尔邦、中央邦、贾坎德邦、奥里萨邦、曼尼普尔邦、米佐拉姆邦、阿鲁纳恰尔邦、泰米尔纳德邦、拉克沙群岛和安达曼和尼科巴群岛,NFHS - 5调查中高血压前期(JNC 7/8)的患病率已超过50%。然而,果阿邦、锡金邦、阿萨姆邦、那加兰邦和西孟加拉邦的高血压前期患病率呈下降趋势。在NFHS - 5中,观察到117个地区为热点(“高高”聚类)聚集区,主要分布在阿鲁纳恰尔邦、拉贾斯坦邦、中央邦、北方邦和旁遮普邦。

结论

我们在基于印度人群的大规模调查中发现高血压前期患病率很高。研究结果还突出了基于不同分类对高血压前期(血压升高或血压正常高值)估计的显著差异。这些结果将有助于指导研究人员、公共卫生政策制定者和临床医生统一界定高血压前期,以便进行有效管理。这些趋势应被视为一个临时警示信号,以制定强有力实施干预措施的指南,预防和控制高血压前期及高血压。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ac/12157057/57841f5eddeb/pone.0325437.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ac/12157057/fbdc97dc996c/pone.0325437.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ac/12157057/18a3db3ba28f/pone.0325437.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ac/12157057/041f68817193/pone.0325437.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ac/12157057/57841f5eddeb/pone.0325437.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ac/12157057/fbdc97dc996c/pone.0325437.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ac/12157057/18a3db3ba28f/pone.0325437.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ac/12157057/041f68817193/pone.0325437.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ac/12157057/57841f5eddeb/pone.0325437.g004.jpg

相似文献

1
Prevalence and determinants of prehypertension (elevated blood pressure or high normal BP) according to different classifications in India during 2015-2021: Evidence from the large national surveys.2015 - 2021年印度不同分类下高血压前期(血压升高或血压正常高值)的患病率及决定因素:来自大型全国性调查的证据
PLoS One. 2025 Jun 11;20(6):e0325437. doi: 10.1371/journal.pone.0325437. eCollection 2025.
2
Spatial heterogeneity in unintended pregnancy and its determinants in India.印度意外妊娠的空间异质性及其决定因素。
BMC Pregnancy Childbirth. 2024 Oct 14;24(1):670. doi: 10.1186/s12884-024-06850-z.
3
Spatial disparities in death registration across states and districts of India, 2019-21.2019 - 2021年印度各邦和地区死亡登记的空间差异
BMC Public Health. 2025 May 10;25(1):1733. doi: 10.1186/s12889-025-22707-2.
4
Spatiotemporal variations and determinants of overweight/obesity among women of reproductive age in urban India during 2005-2021.2005-2021 年印度城市育龄期女性超重/肥胖的时空变化及其决定因素。
BMC Public Health. 2023 Oct 5;23(1):1933. doi: 10.1186/s12889-023-16842-x.
5
Factors associated with inadequate receipt of components and non-use of antenatal care services in India: a regional analysis.印度与产前保健服务组件接受不足和未使用相关的因素:区域分析。
BMC Public Health. 2023 Jan 3;23(1):6. doi: 10.1186/s12889-022-14812-3.
6
Indoor air pollution (IAP) and pre-existing morbidities among under-5 children in India: are risk factors of coronavirus disease (COVID-19)?印度 5 岁以下儿童的室内空气污染 (IAP) 和现有疾病:是否为冠状病毒病 (COVID-19) 的危险因素?
Environ Pollut. 2020 Nov;266(Pt 2):115250. doi: 10.1016/j.envpol.2020.115250. Epub 2020 Jul 15.
7
Spatial Patterns and Determinants of Diabetes Mellitus in Indian Adult Population: a Secondary Data Analysis from Nationally Representative Surveys.印度成年人口中糖尿病的空间模式及决定因素:基于全国代表性调查的二次数据分析
Diabetes Ther. 2023 Jan;14(1):63-75. doi: 10.1007/s13300-022-01329-6. Epub 2022 Nov 3.
8
Prevalence and Determinants of Hypertension in India Based on the 2017 ACC/AHA Guideline: Evidence from the India National Family Health Survey.基于 2017ACC/AHA 指南的印度高血压患病率及其决定因素:来自印度国家家庭健康调查的证据。
Am J Hypertens. 2020 Mar 13;33(3):252-260. doi: 10.1093/ajh/hpz181.
9
Spatial clustering of overweight/obesity among women in India: Insights from the latest National Family Health Survey.印度女性超重/肥胖的空间集聚:最新国家家庭健康调查的见解。
PLoS One. 2024 Jul 24;19(7):e0305205. doi: 10.1371/journal.pone.0305205. eCollection 2024.
10
District-Wise Heterogeneity in Blood Pressure Measurements, Prehypertension, Raised Blood Pressure, and Their Determinants Among Indians: National Family Health Survey-5.印度人血压测量、高血压前期、高血压的地区差异及其决定因素:国家家庭健康调查-5。
Int J Public Health. 2024 Mar 18;69:1606766. doi: 10.3389/ijph.2024.1606766. eCollection 2024.

本文引用的文献

1
2024 ESC Guidelines for the management of elevated blood pressure and hypertension.2024年欧洲心脏病学会高血压管理指南
Eur Heart J. 2024 Oct 7;45(38):3912-4018. doi: 10.1093/eurheartj/ehae178.
2
Prevalence of prehypertension and hypertension among the adults in South Asia: A multinomial logit model.南亚成年人高血压前期和高血压的流行情况:多项逻辑回归模型。
Front Public Health. 2023 Jan 27;10:1006457. doi: 10.3389/fpubh.2022.1006457. eCollection 2022.
3
Asset and consumption gradient of health estimates in India: Implications for survey and public health research.
印度健康评估中的资产与消费梯度:对调查及公共卫生研究的启示
SSM Popul Health. 2022 Oct 4;19:101258. doi: 10.1016/j.ssmph.2022.101258. eCollection 2022 Sep.
4
Gender difference in prevalence of hypertension among Indians across various age-groups: a report from multiple nationally representative samples.印度不同年龄段人群中高血压患病率的性别差异:来自多个全国代表性样本的报告。
BMC Public Health. 2022 Aug 10;22(1):1524. doi: 10.1186/s12889-022-13949-5.
5
Prevalence of hypertension and pre-hypertension in the Middle East region: a systematic review & meta-analysis.高血压和高血压前期在中东地区的流行情况:系统评价和荟萃分析。
J Hum Hypertens. 2022 Sep;36(9):794-804. doi: 10.1038/s41371-021-00647-9. Epub 2022 Jan 15.
6
Prevalence and predictors of prehypertension and hypertension in adult population of rural Southern India-An epidemiological study.印度南部农村成年人口中高血压前期和高血压的患病率及预测因素——一项流行病学研究
J Family Med Prim Care. 2021 Jul;10(7):2558-2565. doi: 10.4103/jfmpc.jfmpc_2415_20. Epub 2021 Jul 30.
7
Regional impact of updated guidelines on prevalence and distribution of blood pressure categories for hypertension in India: Results from the National Family Health Survey 4.更新指南对印度高血压血压分类流行率和分布的区域影响:国家家庭健康调查 4 的结果。
Indian Heart J. 2021 Jul-Aug;73(4):481-486. doi: 10.1016/j.ihj.2021.06.004. Epub 2021 Jun 12.
8
Prevalence of and factors associated with hypertension according to JNC 7 and ACC/AHA 2017 guidelines in Bangladesh.根据美国国家联合委员会第7版(JNC 7)和美国心脏病学会/美国心脏协会(ACC/AHA)2017年指南,孟加拉国高血压的患病率及相关因素。
Sci Rep. 2021 Jul 29;11(1):15420. doi: 10.1038/s41598-021-94947-2.
9
Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension.全球高血压流行病学、健康负担及有效干预措施
Nat Rev Cardiol. 2021 Nov;18(11):785-802. doi: 10.1038/s41569-021-00559-8. Epub 2021 May 28.
10
Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran.2017 ACC/AHA 指南对伊朗西南部高血压患病率、知晓率、治疗率、控制率及决定因素的影响:一项基于人群的横断面研究。
Popul Health Metr. 2021 May 25;19(1):26. doi: 10.1186/s12963-021-00260-5.